InvestorsHub Logo
Followers 51
Posts 9109
Boards Moderated 1
Alias Born 10/25/2007

Re: MiamiGent post# 4

Thursday, 10/27/2022 9:27:00 AM

Thursday, October 27, 2022 9:27:00 AM

Post# of 89
this is very interesting: https://www.healthleadersmedia.com/pharma/just-two-years-helm-ceo-paul-peter-tak-transforms-candel-and-cancer-treatment




CAN-2409 is also being evaluated in multiple phase 2 and phase 3 clinical trials for lung, brain, pancreatic, and prostate cancers.

but we will have more new data and a new cohort of 11 patients in December this year."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CADL News